Home
3D Cell Culture
21 February - 22 February 2018
3D Cell Culture

*** NEW INTERVIEWS RELEASED! ***

Visit the download centrefor some exclusive pre-show interviews with some of our key speakers.

Building on the sell-out success of the launch event, SAE Media Group is delighted to announce the return of 3D Cell Culture, taking place on 21st and 22nd of February 2018, in London UK.

Whilst still in its infancy, 3D Cell Culture is rapidly growing with not only a widespread reach that can be seen across a number of different fields such as 3D bioprinting and microfluidics, but also with incredible potential for industrial application. The 2nd annual conference will explore these overlapping areas and will also update delegates on pioneering developments in surrounding topics such as disease models, organoids, organ-on-a-chip technologies and iPSC advances.
 

Attendee testimonials from 2017:

“Very good presentations and a few outstanding ones...I made some useful contacts” Asterand Bioscience
“The conference was wonderfully organised” Novartis
“Good start, love to see the event occur again” Thermo Fisher Scientific


VIP Offer - To all the SAE Media Group delegates choosing to stay at the Copthorne Tara Hotel, we will offer an upgrade to a superior room and welcome drink voucher

FEATURED SPEAKERS

Christopher Schofield

Christopher Schofield

Investigator, GSK
Max Salick

Max Salick

Postdoctoral Researcher, Novartis Institutes For Biomedical Research
Patrick Kugelmeier

Patrick Kugelmeier

Director of Science, Kugelmeiers
Tudor  Petreus

Tudor Petreus

PostDoctoral Researcher, AstraZeneca

Andrew Spragg

CEO, Jellagen Pty Ltd
Andrew Spragg

Catarina Brito

Lab Head, iBET
Catarina Brito

Christopher Schofield

Investigator, GSK
Christopher Schofield

Chris Schofield is an investigator in the Protein and Cellular Sciences department at GlaxoSmithKline R&D, Stevenage. He obtained his undergraduate degree in Applied Biology from the University of Coventry. Joining GSK in 1995 he has gained over 20 years industrial experience in protein expression supporting small molecule drug discovery. He specialised in development of laboratory and pilot plant scale mammalian and insect cell culture systems including large scale baculovirus, bacMam and other transient systems. His cell culture expertise contributed to the development and implementation of frozen cell technology and the use of frozen isolated mitochondria from cell lines for high throughput screening. He is currently investigating the use of precision cut tissue slices and 3D cell culture models in early drug discovery.

Daniela Loessner

Reader, Barts Cancer Institute
Daniela Loessner

David Pan

Programme Manager (Regenerative Medicine), UK Regenerative Medicine Platform
David Pan

David obtained his PhD from the University of Sydney, Dept of Medicine (Endocrinology) and spent several years in both academic research and drug discovery in the biotech industry at OSI Pharmaceuticals/Prosidion Ltd. David is currently the Programme Manager for the UK Regenerative Medicine Platform (UKRMP). The UKRMP is a £25M initiative, funded by the MRC, EPSRC BBSRC that aims to address technical and scientific challenges associated with translating promising scientific discoveries in this area towards clinical impact. As Programme Manager, he provides the key point of contact between the regenerative medicine community and funding agencies.

Diana Ribeiro

Industrial PhD Student, AstraZeneca
Diana Ribeiro

Fabien Guillemot

CEO, Poietis
Fabien Guillemot

Gary Allenby

Business Development Director and Chief Scientific Officer, Aurelia Bioscience
Gary Allenby

After completing a Ph.D. in reproductive toxicology I post-doc’ed at Hoffmann La Roche U.S.A, studying the pharmacology of retinoid biology. I returned to the U.K. into Lead Generation at Glaxo Wellcome, developing cell-based assays and working with vendors to validate new technologies for screening. In 2000 I joined Hit Identification at AstraZeneca, developing assays for respiratory and inflammatory disease and continuing to work with vendors. In 2011 I became a founding entrepreneur of Aurelia Bioscience, a pre-clinical contract research organisation specialising in the development of cell-based assays for compound and biologics screening. Our unique selling point is the development of more physiological phenotypic assays.
 

Max Salick

Postdoctoral Researcher, Novartis Institutes For Biomedical Research
Max Salick

Max Salick is a postdoctoral scholar in the Neuroscience Department of the Novartis Institutes for Biomedical Research in Cambridge, Massachusetts. Max’s research has merged CRISPR gene-editing, 3D human cerebral organoid models, and high-throughput single cell trascriptomics to uncover the mechanisms of both genetic and infectious neurodevelopmental diseases. Through this combination of molecular, computational, and stem cell biology, Max’s work has helped to unlock the viral tropism of Zika virus, as well as the effects of tuberous sclerosis on brain formation and function.

Nicholas Leslie

Professor, Heriot-Watt University
Nicholas Leslie

Nick is a cancer cell biologist and a Professor at Heriot Watt University in Edinburgh. He studied Genetics at Cambridge and Glasgow Universities before research work at the Beatson Institute for Cancer Research and Dundee University, addressing cellular control mechanisms which are disturbed in many cancers. In particular, Nick has extensively studied the tumour suppressor PTEN, the function of which is disrupted in around a third of all cancers. At HWU, much of his lab’s research is in collaboration with engineers, applying biofabrication methods and other new technologies to cancer research. His 80+ publications currently accumulate >400 citations per year.

Patrick Kugelmeier

Director of Science, Kugelmeiers
Patrick Kugelmeier

Patrick Kugelmeier studied medicine and did his medical thesis in islet transplantation for the treatment of Diabetes. The joy of research led to an MD-PhD program for the early differentiation of stem cells. Cell culture technologies at that time didn't allow for good data reproducibility, because stem cells were cultured in 2D. Fueled by the clinical need of small, size-controlled cell clusters to improve islet transplantation and the insights from the sensitivity of stem cells, he began to develop what was later to become the Sphericalplate 5D.
After the MD-PhD program, he did his clinical training in visceral and transplant surgery followed by trauma surgery. Besides the clinical work, the Sphericalplate 5D was further developed. Finally, it became clear that this technology opens a new dimension in cell transplantation and regenerative medicine and Dr. Kugelmeier decided to quit surgery to fully live this vision within a startup-company, the Kugelmeiers AG.
 

Reyk Horland

Head of Business Development, TissUse GmbH
Reyk Horland

Since 2010 Reyk is actively involved in the development of TissUse’s Multi-Organ-Chip platform for culture analysis of drug candidates, cosmetics, chemicals and consumer products. He currently holds the position of Head of Business Development at TissUse. Prior to TissUse Reyk studied Biotechnology at the Technische Universität Berlin and specialized in Medical Biotechnology. During his academic career, he was involved in various tissue-engineering programs, all with a focus on bringing the respective products to market.

Ricardo Baptista

Lead Scientist Process Development, Cell and Gene Therapy Catapult
Ricardo Baptista

Ricardo Baptista hold the role of Lead Scientist of the Industrialisation Team at The Cell and Gene Therapy Catapult, London, UK. He is currently working on the development of scalable bioprocesses for the manufacture of allogeneic therapies derived from human pluripotent stem cells. He is also involved in projects aiming the automation and translation of bioprocesses for cell therapy manufacture. Previously to Cell Therapy Catapult, Ricardo held the role of Project Manager and Scientist in Product and Process Development Team at CCRM-Centre for Commercialization of Regenerative Medicine, in Canada. Ricardo is a Biological Engineer and obtained his PhD degree in Biotechnology and Biochemical Engineering.

Scott Cribbes

Director of New Technologies and Emerging Markets, Nexcelom
Scott Cribbes

Stefan Kustermann

Lab Head, Roche Pharma Schweiz AG
Stefan Kustermann

Stefan Przyborski

Professor of Cell Technology, University of Durham
Stefan Przyborski

Professor Przyborski holds an academic position as Professor in Cell Technology at Durham University. He has over 25 years experience in cell biology with specific interests in cell culture technology, neuroscience and stem cell research. In recent years he has developed a multi-disciplinary approach through collaborative projects with physical scientists to develop novel ways of solving biological problems. He has formed alliances with pharmaceutical and biotech companies, has published over 100 scientific papers and has filed several patents. He is also the founder and Chief Scientific Officer of Reinnervate (now part of ReproCELL Europe), a biotechnology company founded in 2002 as a spinout from Durham University UK. Professor Przyborski is developing new and innovative ways to manage the growth and function of cultured cells. These enabling technologies have multiple applications and will be particularly relevant to building models of human tissues to advance basic research and drug discovery.
 

Suwan Jayasinghe

Professor of Bioengineering, University College London
Suwan Jayasinghe

Tudor Petreus

PostDoctoral Researcher, AstraZeneca
Tudor  Petreus

2004 - 2014 lecturer and assistant professor of Cell Biology in the University of Medicine and Pharmacy Iasi, Romania (English French and Romanian classes), Laboratory medicine specialist. Erasmus mobility in tissue engineering (France, 2002, 2010, 2011). 2014 - 2016 - postdoc in AstraZeneca UK, implementing Human Microtissue Body-on-a-Chip microfluidic devices to enhance translation of anti-tumour drug efficacy and safety prediction to the clinic. Since 2016, second postdoc in AstraZeneca UK, responsible for development of complex 3D tumour models in microfluidic devices and their use to evaluate the therapeutic index of drug combinations.
 

sponsors

Conference agenda

clock

8:30

Registration & Coffee

clock

9:00

Chairman's Opening Remarks

Stefan Przyborski, Professor of Cell Technology, University of Durham

clock

9:10

3D Cell Culture – A Rapidly Developing Series of Technologies Enabling the Evolution of Complex Models of Human Tissues and In Vitro Assays

Stefan Przyborski, Professor of Cell Technology, University of Durham

  • 3D vs 2D cell culture – the similarities and differences between both methods;
  • Demand for 3D cell culture;
  • No one solution - alternative techniques: organoids, spheroids, hydrogels and scaffolds;
  • Examples of current applications –simple 3D cultures to engineering complex tissues;
  • Case example – building layered tissue structures to model the anatomy and physiology of native counterparts;
  • New developments in 3D cell culture and related technologies
     
  • clock

    9:50

    Electrospun micro-scaffold based biology – a 3-D biology approach to overcome many challenges for well-based screening

    Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Bioscience

    Electrospun scaffold material is used in regenerative medicine to grow, differentiate and deliver stem cells into patients – we have developed practical approaches to use this material for 3-D screening purposes
    Our primary cells, differentiated stem cells and recombinant cells grow on and into micro-scaffold islands, effectively 3-D micro-tissues on a matrix in micro-wells and in media
    By incorporating iron particles into the scaffold material, we can physically manipulate the micro-scaffolds with magnetism, moving these around wells of plates and tubes in culture
    We will show data from a number of assay readouts to exemplify the simplicity of the approach for cell-based phenotypic screening together with advantages of this approach for assay biology

    clock

    10:30

    Morning Coffee

    clock

    11:00

    Next generation jellyfish collagen – Applications for 3D cell culture

    Andrew Spragg

    Andrew Spragg, CEO, Jellagen Pty Ltd

  • Jellyfish collagen biomaterials and why considered to be next generation
  • 2D applications
  • Overview of possible 3D applications
  • Future potential for research and medical applications
  •  

    clock

    11:40

    Modular 3D cell culture platforms to recreate tissue and tumour microenvironments

    Daniela Loessner

    Daniela Loessner, Reader, Barts Cancer Institute

  • Suitability of melt electrospun scaffolds and hydrogels as 3D in vitro niche models and humanised in vivo models
  • Design of 3D models needs to be informed by stage of the human disease, for example early steps of cancer development and progression or metastatic processes
  • Complexity and difficulties of molecular analysis
  • clock

    12:20

    Networking Lunch

    clock

    13:30

    The potential of advanced cell culture models for the understanding of disease and compound testing

    Catarina Brito

    Catarina Brito, Lab Head, iBET

  • There is an increasing demand for the application of more predictable cell models in drug discovery. These models should be able to reflect human tissue properties and functionality more faithfully, enabling to recapitulate in vitro certain features of tissue microenvironment.
  • Pathophysiological-relevant cell models require the existence of cell-cell, cell-extracellular matrix and soluble factors to caption tissue complexity at a certain extent.
  • Increase in complexity of model design must be accompanied by the application of more advanced characterization tools and read-outs.
     
  • clock

    13:30

    Direct tissue engineering approaches for regenerative biology and medicine

    Suwan Jayasinghe

    Suwan Jayasinghe, Professor of Bioengineering, University College London

  • Technological application in cell culture and expansion
  • Biological model development
  • Tissues development in a dish, for drug development and screening etc.
  • Reconstruction of tissues for repair, replacement and rejuvenation
  • clock

    14:50

    Afternoon Tea

    clock

    15:20

    Can 3D cell culture improve the prediction of hepatotoxicity in early phase screening?

    Christopher Schofield, Investigator, GSK

  • Development of a 3D primary human hepatocyte in vitro model
  • Comparison to current 2D and other complex in vitro models
  • Industrialisation for compound screening and further characterisation
  • The results of a validation compound set
  • clock

    16:00

    Merging CRISPR-editing and single cell sequencing technologies to uncover the biology of human neurodevelopmental diseases in 3D: case studies with Zika virus and tuberous sclerosis

    Max Salick, Postdoctoral Researcher, Novartis Institutes For Biomedical Research

  • CRISPR-engineered human stem cell lines mimic disease phenotypes during 3D cerebral organoid differentiation
  • Selective removal of target genes in cerebral organoids reveals the biology of Zika virus infection
  • Whole-genome CRISPR screens enable the discovery of new proteins linked to tropism of emerging infectious diseases
  • Single cell sequencing allows researchers to investigate cell-type specific effects of mutations, treatments, or other perturbations in complex 3D tissues

     

  • clock

    16:40

    The UKRMP – a national strategic initiative

    David Pan, Programme Manager (Regenerative Medicine), UK Regenerative Medicine Platform

  • What are the key challenges for regenerative medicine?
  • What is the ambition and of the UK’s strategic approach?
  • Overview of developments, current standings and forward plans
  • clock

    17:20

    Chairman’s Closing Remarks and Close of Day One

    clock

    8:30

    Registration & Coffee

    clock

    9:00

    Chairman's Opening Remarks

    Gary Allenby

    Gary Allenby, Business Development Director and Chief Scientific Officer, Aurelia Bioscience

    clock

    9:10

    The overlap of 3D bioprinting and 3D cell culturing in Cancer Research

    Nicholas Leslie, Professor, Heriot-Watt University

  • Overview of 3D bioprinting
  • The reliance of 3D bioprinting on spheroid models and cell organisation
  • How to achieve correct architecture, based on different disease models
  • How improving placement of cells in printing can translate into improved model
  • The synonymy of 3D bioprinting and 3D cell culture
     
  • clock

    9:50

    Multi-Organ-Chip technology: A completely new approach to predictive substance testing

    Reyk Horland, Head of Business Development, TissUse GmbH

  • Definition and overview of Organ-on-a-Chip (OOC) systems
  • Scientific concept, design principles and fabrication of OOC
  • Case studies on industrial applications off OOC
  • Qualification and validation of OOC
  • Roadmap towards individual “Patients-on-a-Chip”
  • clock

    10:30

    Morning Coffee

    clock

    11:00

    Complex co-cultured spheroids to validate tumour models in microfluidic devices

    Tudor Petreus, PostDoctoral Researcher, AstraZeneca

  • Overview on the tumour-on-chip models
  • Development of in vitro prevascularized minitumours – current progress and optimization
  • Prevascularized tumour models in cancer research
  • clock

    11:40

    Keep up to speed with fast whole well imaging using the Celigo image cytometer for all your 2D and 3D assay needs

    Scott Cribbes

    Scott Cribbes, Director of New Technologies and Emerging Markets, Nexcelom

  • Physiologically relevant screening models
  • Immunoncology, Spheroids and Organoids assays
  • Automated Virology research tool
  • clock

    12:20

    Networking Lunch

    clock

    13:30

    3D cellular models for drug safety assessment: an industry perspective

    Stefan Kustermann

    Stefan Kustermann, Lab Head, Roche Pharma Schweiz AG

     

  • There is a strong need for complex in vitro models for drug safety assessment recapitulating human physiology to a high degree
  • This is supported by an ever increasing complexity of modalities and targets with a strong need for human in vitro models
  • Novel human 3D cellular models will be presented and their impact for drug safety assessment will be discussed
  • clock

    14:10

    How laws of nature should guide the development of 3D cell culture for regenerative medicine

    Patrick Kugelmeier, Director of Science, Kugelmeiers

  • We are learning the language of life. Stem cell communication principles.
  • First principle reasoning – how stem cell communication principles influence medical device development
  • Challenges on the way to the largest evolution of medicine in history
  • clock

    14:50

    Afternoon Tea

    clock

    15:20

    Towards bioprinting industrialisation

    Fabien Guillemot

    Fabien Guillemot , CEO, Poietis

  • Designing and manufacturing bio-printed products for regenerative medicine

  • Preclinical research and evaluation of the efficacy of cosmetic products and ingredients

  • The ability to design and manufacture tissues with a single cell resolution

  • Ensuring precise control of the manufacturing process and guarantee the reproducibility and reliability of bio-printed products

  • clock

    16:00

    3D-culture strategies for the generation of stem cell-derived beta cells

    Diana Ribeiro

    Diana Ribeiro, Industrial PhD Student, AstraZeneca

  • Comparison of 2D vs 3D culture on stem cell derived pancreatic models.

  • 3D-culture effect on islets phenotype and function in vitro.

  • Applications of decellularized pancreas tissue for stem cell differentiation

     

  • clock

    16:40

    Development of processing platforms for allogeneic cell therapy manufacturing

    Ricardo Baptista, Lead Scientist Process Development, Cell and Gene Therapy Catapult

  • Expansion of pluripotent stem cells in 2D and 3D culture systems
  • Starting materials compliant with industry standards and regulatory requirements
  • Medium performance
  • Process intensification
  • clock

    17:20

    Chairman’s Closing Remarks and Close of Day Two


    CEO
    Jellagen Pty Ltd
    Lab Head
    iBET
    Investigator
    GSK
    Reader
    Barts Cancer Institute
    Programme Manager (Regenerative Medicine)
    UK Regenerative Medicine Platform
    Industrial PhD Student
    AstraZeneca
    CEO
    Poietis
    Business Development Director and Chief Scientific Officer
    Aurelia Bioscience
    Postdoctoral Researcher
    Novartis Institutes For Biomedical Research
    Professor
    Heriot-Watt University
    Director of Science
    Kugelmeiers
    Head of Business Development
    TissUse GmbH
    Lead Scientist Process Development
    Cell and Gene Therapy Catapult
    Director of New Technologies and Emerging Markets
    Nexcelom
    Lab Head
    Roche Pharma Schweiz AG
    Professor of Cell Technology
    University of Durham
    Professor of Bioengineering
    University College London
    PostDoctoral Researcher
    AstraZeneca

    Sponsors and Exhibitors

    Official Media Partner

    Supporters

    [ATTENDEE LIST] - 3D Cell Culture

    Download

    [SPEAKER INTERVIEW] - Reyk Horland, TissUse GmbH

    Download

    [SPEAKER INTERVIEW] - Vitor Santo, Immunocore

    Download

    [SPEAKER INTERVIEW] - Stefan Przyborski, Durham University / ReproCELL Europe

    Download

    [SPEAKER INTERVIEW] - Gary Allenby, Aurelia Bioscience

    Download

    [SPEAKER INTERVIEW] - Patrick Kugelmeier, Kugelmeiers

    Download

    Sponsors and Exhibitors


    BioreclamationIVT

    Sponsors and Exhibitors
    http://www.bioreclamationivt.com

    BioreclamationIVT is a trusted supplier of ethically-acquired biospecimens and research services. Disease indications from numerous sample types (biofluids, cells, matched normal/metastasized tissues) and are accessible through a network of over 200 clinical sites. With exceptional customer service and quality products and services, BioreclamationIVT is your research partner in ELEVATING SCIENCE.


    Bio-Techne

    Sponsors and Exhibitors
    http://www.bio-techne.com

    Bio-Techne® unites some of the most referenced brands in Life Sciences: R&D Systems™, Novus Biologicals™, Tocris™, ProteinSimple™ and Advanced Cell Diagnostics™ (ACD). Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is proud to be supporting the 11th Annual RNA Therapeutics Conference, to assist in the development of RNA Therapeutics.

    The highly specific and sensitive single-molecule RNAscope® and BaseScope™ RNA ISH technologies from ACD, address key questions about therapeutic gene delivery vectors (both viral and non-viral) and therapeutic transgene expression. With the ability to visualize RNA at single molecule and single cell resolution, RNAscope technology is a solution for both the development and production of RNA therapeutics. As a reproducible and consistent assay to validate gene therapies between and within laboratories, it can be used to measure potency of vectors through quantification of copy numbers and transgene expression. The RNA ISH technology can also be a powerful tool in the understanding of vector and transgene expression with morphological context in tissue allowing differentiation of transgene from endogenous mRNAs, confirmation of gene-editing based therapies (CRISPR/Cas9) and off target effects.

    With constant development of our technology and for new applications RNAscope technologies, Advanced Cell Diagnostics (ACD), a Bio-Techne brand, is proud to be supporting the 11th Annual RNA Therapeutics Conference, to assist in the development of RNA Therapeutics. Please join us at our booth to explore how our products and services can assist in your therapeutic discovery and development.



    Integra Biosciences

    Sponsors and Exhibitors
    http://www.integra-biosciences.com

    INTEGRA is a leading provider of high-quality laboratory tools for liquid handling and media preparation. We are committed to fulfil the needs of our customers in research, diagnostics and quality control within the life science and medical industry. Our worldwide known products include VIAFLO Electronic Pipettes, PIPETBOY Serologic Pipettors, VACUSAFE and VACUSIP Aspiration Systems, DOSE IT Peristaltic Pumps, FIREBOY Safety Bunsen Burners, MEDIACLAVE and MEDIAJET Media Preparation Equipment and VIAFILL Reagent Dispensers. Visit www.integra-biosciences.com to see our groundbreaking VIAFLO Assist and VIAFLO 96/384 Channel Electronic Pipette. INTEGRA is headquartered in Zizers, Switzerland and Hudson NH, USA maintaining direct sales organisations in the USA, Switzerland, Germany, UK, France and Austria as well as a worldwide network of over 90 distribution partners.


    Jellagen

    Sponsors and Exhibitors
    http://www.jellagen.co.uk/

    Jellagen Pty Ltd is a Med-Tech business manufacturing next generation collagen products sourced from Jellyfish for application in 2D and 3D cell culture and medical devices. Jellagen’s research grade materials are distributed into the global cell culture and stem cell research markets. Jellagen’s collagen products offers the potential of in vitro to in vivo applications as well as batch to batch consistency offering advantages to research and medical applications.


    Nexcelom

    Sponsors and Exhibitors
    http://www.nexcelom.co.uk

    Nexcelom’s Cellometer and Celigo S image cytometry products are designed for cell analysis in life science and biomedical research. The Cellometer instruments cover basic cell counting, viability and cell-based assays with 20uL of sample. The Celigo S is a high throughput fast micro-well 2D and 3D image cytometer. Nexcelom products are help researchers all over the world.

    Media Partners


    RegMedNet

    Official Media Partner
    https://www.regmednet.com

    RegMedNet is a networking site that unites all members of the diverse regenerative medicine community, enabling them to share the latest news, inspiration and insights, and connect and collaborate in order to help this exciting field move forward at an even faster rate.


    3DMedNet

    Official Media Partner
    https://www.3dmednet.com/

    3DMedNet is an online community providing the latest news, opinions and peer-reviewed journal articles focused on the applications of 3D printing technologies in medicine, including 3D-printed medical devices, surgery, pharmaceuticals, bioprinting, dentistry and the regulatory landscape. Visit 3DMedNet today at: www.3dmednet.com

    Media Partners


    Technology Networks

    Supporters
    http://go.technologynetworks.com/subscribe-to-newsletters

    Founded in 2000, Technology Networks is established as the leading news provider for life science and drug discovery professionals. In addition, we provide unique content including webcasts, videos, application notes and posters from recent conferences. Our portfolio now includes around 30 focussed scientific communities, all of which are accessible free of charge within TechnologyNetworks.com


    Drug Discovery Today

    Supporters
    http://www.drugdiscoverytoday.com/

    Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


    Bentham Science

    Supporters
    http://www.benthamscience.com/

    Bentham Science Publishers is a major STM journal publisher of 130 plus print and online journal. Out of these, 40 journals have already registered good IMPACT FACTORS as per Journal Citation Reports® 2017. These titles have extensive readership mostly in Europe and North America. For a detailed profile please visit our website at http://www.benthamscience.com. Besides, Bentham Science publishes eBooks in all areas of Science, Technology and Medicine. Our eBooks provide professionals, academicians, corporate researchers, graduates and undergraduates worldwide with the most current information in their subject areas of interest. Our eBooks are also available in the ePub and Kindle formats besides the PDF edition here http://ebooks.benthamscience.com/. Bentham is offering attendees of this conference discounts on its publication. For more information click here


    Drug Target Review

    Supporters
    http://www.drugtargetreview.com

    Drug Target Review’s quarterly magazine, website and annual events program provides high quality content with peer-written articles that are submitted exclusively by the world’s most respected scientists in their field. This attracts a committed base of readers, users and delegates made up of senior decision-makers from the life science and drug discovery industries at the top pharmaceutical companies, as well as academics and scientists from the top research institutes across the globe.


    Gate2Biotech

    Supporters
    http://www.gate2biotech.com

    Gate2Biotech is a portal that unites biotechnological community in Central Europe. It covers all the news in the field of biotechnology. Thanks to the the portal the companies engaged in the field can easily search for research institutions and other partners to solve technical problems they are facing and here they can also present their services offer to potential partners from the Czech Republic and abroad. Gate2Biotech portal serves as a bridge connecting scientific and commercial sector. It incorporates offices and support organizations dedicated to promoting transfer of innovative technologies into a unified communication platform of Czech and international biotechnologies. As a mediator of information it draws attention to biotechnologies and support of their application and transfer into practice. It also functions as a tool for encouraging non-professionals (especially scientists and students) towards innovative business or applied research.


    Pharmavision

    Supporters
    http://www.pharmavision.co.uk

    PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


    International Pharmaceutical Industry

    Supporters
    http://www.ipimediaworld.com

    IPI gives you an insight into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. IPI provides a proven supportive means of communication to the Pharmaceutical, Bio Pharmaceutical, Nutraceutical and Medical Devices industry, incorporating the latest in research and technology innovations, regulatory guidelines, marketing and communication strategies.


    Biosave

    Supporters
    http://www.Biosave.com

    Biosave.com brings together the best Life Science promotions, product releases, featured products, publications, videos and events from 100’s of leading Life Science suppliers. Updated 24 hours a day, Biosave is constantly uploading special promotions and exciting product news that you won’t find anywhere else. Our goal is to provide our users with the most exclusive product information to help reach that all important purchasing decision.


    Pharmaceutical Technology

    Supporters
    http://www.pharmaceutical-technology.com

    Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


    GBI

    Supporters
    http://www.gbihealth.com/

    GBI is an information, applications, and services company focused on the healthcare industry. Leveraging data from across the healthcare value chain, GBI creates web and mobile applications that enable individuals and organizations to make better decisions and communicate more effectively.


    SciDoc Publishers

    Supporters
    http://www.scidoc.org

    SciDoc Publishers is a major source provider of e-journals in the field of Science, Technology and Medicine (STM). The nature of journals - Open Access and Peer-reviewed. We are aimed with a sole motive in making a mark in the field of Open Access, by propagating the knowledge to the scientific community. Our prime concern involves, the knowledge to reach millions of readers and give them access to scientific publications - online.


    CanBiotech

    Supporters
    http://www.canbiotech.com

    CanBiotech - A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the BioMedical Outsourcing Report and the Bio Outsourcing Asia© Publication.


    Labsave

    Supporters
    http://www.labsave.com

    Labsave is the leading savings website for Laboratory Equipment and Lab Supplies. We work closely with the top suppliers in the world to bring you the best products at the most competitive prices. We are constantly striving to secure the biggest and most exclusive offers that you won’t find anywhere else! http://www.labsave.com/


    Labiotech.eu

    Supporters
    https://goo.gl/DRE2Gp

    Labiotech.eu is the leading digital media covering the European Biotech industry. Over 100,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you'll enjoy reading our stories!


    Absave

    Supporters
    http://www.absave.com

    Absave.com is the leading savings website for Antibodies and Immunological Products. Search our extensive database of Antibodies, Kits, Proteins & Peptides, Reagents, etc. to find the best savings!


    Pharmalicensing

    Supporters
    http://www.pharmalicensing.com

    Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.


    Drug Development Technology

    Supporters
    http://www.drugdevelopment-technology.com

    Drugdevelopment-technology.com covers every aspect of the drug development and research process, from conception to pre-FDA approval. Our global network of journalists updates the site with the latest and most significant industry developments. This coverage allows us to provide everyone - from senior management through to research and QA staff – with in-depth reviews of the latest projects, advance notice of new product releases and analysis of the latest procedural and legislative developments.


    Samedan

    Supporters
    http://www.samedanltd.com/magazine/13.

    International Clinical Trials (ICT) is a quarterly magazine edited by Dr Graham Hughes, and written by specialists at the forefront of clinical research. ICT’s coverage of operational developments ranges from adaptive designs in early phase trials through to post marketing research. ICT’s targeted readership consists of key decision makers across the pharmaceutical and biotech industries, along with contract partners and consultants. The magazine is distributed to pharmaceutical professionals in Europe and North America, and is accessed globally online. Read the latest issues, explore the ICT archive and subscribe at www.samedanltd.com/magazine/13.


    Mednous

    Supporters
    http://www.MedNous.com

    MedNous is a print publication and website about medical innovation in Europe. It carries exclusive interviews with companies that are at the forefront of medical technology, as well as contributor articles from prominent practitioners. Our mission is to identify significant advances in medicine and to explain how this innovation is being commercialised. In doing so, we talk to venture capitalists about what products and platforms they are supporting. We report on how regulators cope with the accelerating pace of innovation. And we regularly cover the latest developments in the discovery and development of new medical concepts in the area of antibodies, vaccines, small molecules, regenerative medicine and nanomedicines. MedNous combines the English word for medicine with the Greek word for intellect. And those with nous are readers of our publication. Visit our website: www.mednous.com


    Swiss Biotech Association

    Supporters
    http://www.swissbiotech.org/

    The Swiss Biotech Association (SBA) is the national industry association for biotechnology, including pharmaceuticals, diagnostics, agriculture, food, cosmetics, environmental biotechnology, and specialty chemicals. Members are companies active in modern biotechnology, such as R&D, Production, Marketing and Sales, Finance, Services and Consulting. SBA provides a networking platform for Life Science clusters, academic and federal institutions the like. Founded in March 1998, the Association grows steadily.


    PWTV

    Supporters
    www.pharmaworld.tv

    The dedicated Audio Visual file sharing platform for the Pharmaceutical, Life Sciences and The Animal Health Industry. Use the power of Audio and Visual to give a clearer information to your clients. www.pharmaworld.tv


    Biocompare

    Supporters
    http://www.biocompare.com

    Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


    Select Science

    Supporters
    http://www.selectscience.net/

    SelectScience is an independent, online information resource for the worldwide scientific community, and the home of trusted information for laboratory scientists. Discover impartial, expert opinion and trusted reviews about latest laboratory equipment and techniques; plus videos, application notes and science news from around the world. Become a member for free today.

    Copthorne Tara Hotel

    Scarsdale Place
    Kensington
    London W8 5SR
    United Kingdom

    Copthorne Tara Hotel

    The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

    The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

     

    HOTEL BOOKING FORM

    Title

    SubTitle
    speaker image

    Content


    Title


    Description

    Download

    Title


    Description

    Download

    Title


    Description


    Download


    WHAT IS CPD?

    CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

    ‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

    CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

    Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

    CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

    CPD AND PROFESSIONAL INSTITUTES

    There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

    For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

    CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

    TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

    Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

    ‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

    ‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

    The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

    As a formal provider of CPD certified activities, SAE Media Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

    GLOBAL CPD

    Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

    CPD Certificates

    We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@saemediagroup.com

    Event Title

    Headline

    Text
    Read More

    I would like to speak at an event

    I would like to attend an event

    Group Booking

    Please complete the below form and a member of SAE Media Group’s booking team will be in contact within 24 hours

    I would like to sponsor/exhibit at an event

    SIGN UP OR LOGIN

    Sign up
    Forgotten Password?

    Contact SAE Media Group

    UK Office
    Opening Hours: 9.00 - 17.30 (local time)
    SAE Media Group , Ground Floor, India House, 45 Curlew Street, London, SE1 2ND, United Kingdom
    Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
    Website: http://www.smgconferences.com Email: events@saemediagroup.com
    Registered in England - SMi Group Ltd trading as SAE Media Group




    Forgotten Password

    Please enter the email address you registered with. We will email you a new password.

    Thank you for visiting our event

    If you would like to receive further information about our events, please fill out the information below.

    By ticking above you are consenting to receive information by email from SAE Media Group.
    Full details of our privacy policy can be found here https://www.smgconferences.com/privacy-legals/privacy-policy/.
    Should you wish to update your contact preferences at any time you can contact us at data.privacy@smgconferences.com.
    Should you wish to be removed from any future mailing lists please click on the following link http://www.smgconferences.com/opt-out

    Fill in your details to download the brochure

    By submitting this form you agree to our privacy policy and consent to receiving communications, you may opt out at any time.